Cargando…

Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model

BACKGROUND: Scottish Government is increasing independent prescribers (IP) in community pharmacy (CP). A new preceptorship model using IPs as Designated Prescribing Practitioners (DPPs) has been introduced. AIM: To investigate stakeholder views of implementation of a novel regulator mandated IP cour...

Descripción completa

Detalles Bibliográficos
Autores principales: Jebara, Tesnime, McIntosh, Trudi, Stewart, Fiona, Osprey, Adam, Bruce, Rachel, Cunningham, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618536/
https://www.ncbi.nlm.nih.gov/pubmed/35951218
http://dx.doi.org/10.1007/s11096-022-01467-8
_version_ 1784821071586787328
author Jebara, Tesnime
McIntosh, Trudi
Stewart, Fiona
Osprey, Adam
Bruce, Rachel
Cunningham, Scott
author_facet Jebara, Tesnime
McIntosh, Trudi
Stewart, Fiona
Osprey, Adam
Bruce, Rachel
Cunningham, Scott
author_sort Jebara, Tesnime
collection PubMed
description BACKGROUND: Scottish Government is increasing independent prescribers (IP) in community pharmacy (CP). A new preceptorship model using IPs as Designated Prescribing Practitioners (DPPs) has been introduced. AIM: To investigate stakeholder views of implementation of a novel regulator mandated IP course preceptorship model. METHOD: A theory-based online pre-piloted survey of stakeholders including e.g. directors of pharmacy, prescribing, education leads, policy & strategy leads and CPs. Questionnaire development used Consolidated Framework for Implementation Research (CFIR) and a DPP Competency Framework. Data were analysed descriptively and presented with mapping to CFIR constructs. RESULTS: Of ninety-nine responses 82.5% (80/97) responded ‘yes’ to ‘..abilities in reporting concerns..’ and 53.1% (51/96) indicating ‘no’ to ‘..anticipated issues with clinical and diagnostic skills’. CFIR related facilitators included agreement that; there was tension for change with 84 (85%) indicating ‘….urgent need to implement role …’, that incentives are likely to help (6566%) and small pilots would help (8588%). Barriers were evident related to ‘unsure’ responses about sufficiency of; DPP capacity (39/97, 40.2%), time (48/96, 50%) and support and resources (4445%) to undertake the role. Concerns were expressed with 81 (83%) in agreement or unsure that leadership commitment may be lacking and 48 (48.9%) were ‘unsure’ about availability of good training for the DPP role. CONCLUSION: There was DPP role positivity but expressed barriers and facilitators at policy, organisational and individual practitioner levels needing further consideration. Further research is warranted on uptake and embedding of the role.
format Online
Article
Text
id pubmed-9618536
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96185362022-11-01 Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model Jebara, Tesnime McIntosh, Trudi Stewart, Fiona Osprey, Adam Bruce, Rachel Cunningham, Scott Int J Clin Pharm Research Article BACKGROUND: Scottish Government is increasing independent prescribers (IP) in community pharmacy (CP). A new preceptorship model using IPs as Designated Prescribing Practitioners (DPPs) has been introduced. AIM: To investigate stakeholder views of implementation of a novel regulator mandated IP course preceptorship model. METHOD: A theory-based online pre-piloted survey of stakeholders including e.g. directors of pharmacy, prescribing, education leads, policy & strategy leads and CPs. Questionnaire development used Consolidated Framework for Implementation Research (CFIR) and a DPP Competency Framework. Data were analysed descriptively and presented with mapping to CFIR constructs. RESULTS: Of ninety-nine responses 82.5% (80/97) responded ‘yes’ to ‘..abilities in reporting concerns..’ and 53.1% (51/96) indicating ‘no’ to ‘..anticipated issues with clinical and diagnostic skills’. CFIR related facilitators included agreement that; there was tension for change with 84 (85%) indicating ‘….urgent need to implement role …’, that incentives are likely to help (6566%) and small pilots would help (8588%). Barriers were evident related to ‘unsure’ responses about sufficiency of; DPP capacity (39/97, 40.2%), time (48/96, 50%) and support and resources (4445%) to undertake the role. Concerns were expressed with 81 (83%) in agreement or unsure that leadership commitment may be lacking and 48 (48.9%) were ‘unsure’ about availability of good training for the DPP role. CONCLUSION: There was DPP role positivity but expressed barriers and facilitators at policy, organisational and individual practitioner levels needing further consideration. Further research is warranted on uptake and embedding of the role. Springer International Publishing 2022-08-11 2022 /pmc/articles/PMC9618536/ /pubmed/35951218 http://dx.doi.org/10.1007/s11096-022-01467-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Jebara, Tesnime
McIntosh, Trudi
Stewart, Fiona
Osprey, Adam
Bruce, Rachel
Cunningham, Scott
Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title_full Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title_fullStr Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title_full_unstemmed Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title_short Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
title_sort designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618536/
https://www.ncbi.nlm.nih.gov/pubmed/35951218
http://dx.doi.org/10.1007/s11096-022-01467-8
work_keys_str_mv AT jebaratesnime designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel
AT mcintoshtrudi designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel
AT stewartfiona designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel
AT ospreyadam designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel
AT brucerachel designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel
AT cunninghamscott designatedprescribingpractitionersatheorybasedcrosssectionalstudyofstakeholdersviewsonimplementationofanovelpharmacyregulatormandatedpreceptorshipmodel